Wikisage, the free encyclopedia of the second generation, is digital heritage
Stiripentol: Difference between revisions
Jump to navigation
Jump to search
m (categ) |
(→Links) |
||
| Line 18: | Line 18: | ||
[http://flexikon.doccheck.com/de/Stiripentol FLexikon:Stiripentol] | [http://flexikon.doccheck.com/de/Stiripentol FLexikon:Stiripentol] | ||
{{Wikidata|Q412182}} | {{Wikidata|Q412182}} | ||
Revision as of 15:59, 29 October 2018
Stipiripentol is adjuvant of clobazam and valproic acid[1][2] [3]
Use
Dravet's Syndrome
Stiripentol for Dravet Syndrome: Is It Worth It?[5] [6][7][8][9]
-Stiripentol_Structural_Formulae_V.1.svg.png)
Links
Notes
- ↑ Chiron Catherine 2007 Neurotherapeutics 123-125
- ↑ Pharmacological Reports
- ↑ Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652007/pdf/nihms266887.pdf
- ↑ https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png
- ↑ Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- ↑ Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABAA-Receptor Channels
- ↑ http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf
- ↑ http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf
- ↑ The European patient with Dravet syndrome: Results from abparent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
